This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Biotech

Stocks Recover From Last Week's Selloff, but Expect More Volatility Ahead

After a major sell-off in the biotech space last week, the Dow Jones Industrial Average rose 1.5% on Monday amid a flurry of M&A activity in the pharmaceuticals space.

03/30/15 - 11:22 AM EDT

Teva Buys Tourette Syndrome Drug Firm Auspex for $3.2 Billion

The Israeli drug company thinks the biopharmaceutical drug developer will strengthen its position in its core central nervous system segment.

03/30/15 - 01:25 PM EDT

Stocks Recover From Last Week's Selloff, but Expect More Volatility Ahead

Stocks Recover From Last Week's Selloff, but Expect More Volatility Ahead

After a major sell-off in the biotech space last week, the Dow Jones Industrial Average rose 1.5% on Monday amid a flurry of M&A activity in the pharmaceuticals space.

03/30/15 - 11:22 AM EDT

UnitedHealth Group (UNH) Stock Gains Today on $12.8 Billion Acquisition of Catamaran

UnitedHealth Group (UNH) Stock Gains Today on $12.8 Billion Acquisition of Catamaran

  • Tickers in this article:
  • UNH

UnitedHealth Group (UNH) shares are rising on heavy volume after the company announced the purchase of Catamaran (CTRX) for nearly $13 billion.

03/30/15 - 11:23 AM EDT

Intrexon (XON) Stock Spikes Today on Developmental Collaboration with Merck Serono

Intrexon (XON) Stock Spikes Today on Developmental Collaboration with Merck Serono

  • Tickers in this article:
  • XON

Intrexon (XON) shares are gaining on heavy volume today following CAR-T treatment collaboration with Merck Serono.

03/30/15 - 10:29 AM EDT

Teva Buying Auspex Pharma for $3.5 Billion in Bid to Restart Growth

Teva Buying Auspex Pharma for $3.5 Billion in Bid to Restart Growth

Teva said it would acquire smaller companies as a way to offset the expected revenue hit coming when its multiple sclerosis drug Copaxone faces generic competition in September.

03/30/15 - 07:41 AM EDT

Jim Cramer -- There's No Bubble in Biotech or Semiconductor Sectors

Jim Cramer -- There's No Bubble in Biotech or Semiconductor Sectors

Some of Cramer's favorite companies are rising with their sectors Friday.

03/27/15 - 11:23 AM EDT

Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study

Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study

The GFT505 study in NASH failed, analysts said. That's bad for Genfit and good for Intercept Pharmaceuticals, which is developing a rival drug for fatty liver known as OCA.

03/27/15 - 09:40 AM EDT

ZS Pharma, Gilead & Anacor: BioTech Stock Picks on Sell-Off

ZS Pharma, Gilead & Anacor: BioTech Stock Picks on Sell-Off

Biotech stocks are once again lower after leading Wednesday's market sell-off as investors jump out of the sector as fast as they can.

03/26/15 - 11:39 AM EDT

Semiconductor Stocks Are Getting Hammered Even More Than Biotech

Semiconductor Stocks Are Getting Hammered Even More Than Biotech

Wall Street is fixating on the recent biotech pullback, but the semiconductor sector saw even steeper declines, which worries one strategist.

03/26/15 - 12:57 PM EDT

'Don't Panic' Over Biotech Pullback, Especially After Last Week's Rally, Says Strategist

'Don't Panic' Over Biotech Pullback, Especially After Last Week's Rally, Says Strategist

This week's biotech pullback was largely a matter of giving up gains from last week's Federal Reserve rally.

03/26/15 - 12:14 PM EDT

Here's an 'Attractive Entry Point' for Investors to Get Back Into Stocks

Here's an 'Attractive Entry Point' for Investors to Get Back Into Stocks

This week's biotech-led selloff in stocks is paving the way for buying opportunities down the road, one strategist says. A key indicator is the S&P 500, currently around 2,051.

03/26/15 - 10:55 AM EDT

Celgene (CELG) Stock Declines Today as Bubble Fears Grow

Celgene (CELG) Stock Declines Today as Bubble Fears Grow

  • Tickers in this article:
  • CELG

Celgene (CELG) shares are down as the company was caught up in today's biotech selloff that saw the index drop by 3% in trading today.

03/25/15 - 04:35 PM EDT

Dow Drops Three-Days in a Row, Chevron & Exxon Only Blue Chip Gainers

Dow Drops Three-Days in a Row, Chevron & Exxon Only Blue Chip Gainers

U.S. stocks fell for the third straight session at Wednesday's closing bell.

03/25/15 - 04:39 PM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 17,976.31 +263.65 1.49%
S&P 500 2,086.24 +25.22 1.22%
NASDAQ 4,947.4410 +56.2220 1.15%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs